|1.||Amsterdam, Abraham: 4 articles (07/2013 - 08/2005)|
|2.||Komurasaki, Toshi: 4 articles (03/2008 - 05/2003)|
|3.||Shezen, Elias: 3 articles (07/2013 - 11/2011)|
|4.||Schreiber, Letizia: 3 articles (07/2013 - 11/2011)|
|5.||Raanan, Calanit: 3 articles (07/2013 - 11/2011)|
|6.||Slilat, Yasmin: 3 articles (07/2013 - 11/2011)|
|7.||Wistuba, Ignacio I: 3 articles (09/2012 - 08/2008)|
|8.||Nanney, Lillian B: 3 articles (05/2007 - 05/2003)|
|9.||Nexø, Ebba: 3 articles (01/2007 - 05/2004)|
|10.||Sørensen, Boe Sandahl: 3 articles (01/2007 - 05/2004)|
04/01/2014 - "Deregulated epiregulin activity appears to contribute to the progression of a number of different malignancies, including cancers of the bladder, stomach, colon, breast, lung, head and neck, and liver. "
04/01/2014 - "Epiregulin: roles in normal physiology and cancer."
07/01/2013 - "We also found that the cytoplasm of low grade tumors was positive for epiregulin, while this labeling decreased in high-grade tumors. "
08/28/2011 - "The PGE(2)-dependent NR4A2 induction is essential for the resistance to anti-cancer drug-induced apoptosis especially in SCC cells which showed constitutive EGFRs activity via autocrine epiregulin, a ligand for EGFRs. "
12/19/2008 - "We investigated the regulatory mechanism of epiregulin expression in Ki-ras-transformed cancer cells. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
04/01/2013 - "Using comparative whole-genome expression profiling, we observed differential expression of epiregulin (EREG) in mouse models of colitis-associated, but not sporadic, colorectal cancer. "
06/01/2013 - "The purpose of our study is to examine whether there is a correlation between the presence of colorectal cancer K-ras mutations and the level of expression of EpireguLin and Amphiregulin in the malignant tissue. "
05/27/2014 - "Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer."
02/04/2014 - "Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer."
01/01/2010 - "Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics."
|3.||Neoplasm Metastasis (Metastasis)
02/01/2009 - "Conclusively, the results suggest that epiregulin may play an important role in lung metastasis of SACC."
08/01/2008 - "Additional studies are warranted in NSCLC patients to evaluate whether epiregulin expression predicts the metastatic potential of primary tumors and whether anti-epiregulin treatment strategies are efficacious in the prevention of metastasis."
08/01/2008 - "In NSCLC biopsy samples, epiregulin was detected in 237 of 366 (64.7%) tumors, which correlated with nodal metastasis and a shorter duration of survival. "
01/15/2015 - "In cells where KAP1 was silenced, we identified multiple downregulated genes linked to tumor progression and metastasis, including EREG/epiregulin, PTGS2/COX2, MMP1, MMP2, and CD44, along with downregulation of multiple KRAB-ZNF proteins. "
01/01/2012 - "Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases."
10/01/2003 - "Additionally, we performed in situ hybridization studies to localize 10 mRNAs, melanocyte-specific gene 1, amino acid transporter SN2, overexpressed and amplified in teratocarcinoma (Bcat1), Forkhead box protein FOXO1, 24p3, vascular cell adhesion molecule, epiregulin, Bcl2-like10, PC3B, and retinoblastoma binding protein 7. These 10 genes have expression patterns and postulated functions suggesting that they mediate important processes in the physiology and pathology of ovarian and adrenal tissue."
04/01/2012 - "tuberculosis-stimulated macrophage gene expression profiling in conjunction with a case-control genetic association study to discover epiregulin (EREG), as a novel candidate tuberculosis (TB) susceptibility gene. "
04/01/2012 - "Epiregulin (EREG) variation is associated with susceptibility to tuberculosis."
|1.||amphiregulin (schwannoma-derived growth factor)
|2.||Epidermal Growth Factor (EGF)
|4.||Epidermal Growth Factor Receptor (EGF Receptor)
|6.||Retinoblastoma-Binding Protein 7
|7.||Amino Acid Transport Systems (Amino Acid Transporter)
|8.||Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
|10.||Messenger RNA (mRNA)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)